GB201206323D0 - Methods and arrays for use in the same - Google Patents

Methods and arrays for use in the same

Info

Publication number
GB201206323D0
GB201206323D0 GBGB1206323.6A GB201206323A GB201206323D0 GB 201206323 D0 GB201206323 D0 GB 201206323D0 GB 201206323 A GB201206323 A GB 201206323A GB 201206323 D0 GB201206323 D0 GB 201206323D0
Authority
GB
United Kingdom
Prior art keywords
same
arrays
test sample
methods
determining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1206323.6A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immunovia AB
Original Assignee
Immunovia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunovia AB filed Critical Immunovia AB
Priority to GBGB1206323.6A priority Critical patent/GB201206323D0/en
Publication of GB201206323D0 publication Critical patent/GB201206323D0/en
Priority to US14/391,144 priority patent/US20150057177A1/en
Priority to MX2014012192A priority patent/MX2014012192A/es
Priority to JP2015505056A priority patent/JP6470681B2/ja
Priority to AU2013248138A priority patent/AU2013248138B2/en
Priority to CN201710403116.3A priority patent/CN107782901A/zh
Priority to KR1020147031565A priority patent/KR20140143457A/ko
Priority to EP13775332.3A priority patent/EP2836838A4/en
Priority to CN201380029458.3A priority patent/CN104508486B/zh
Priority to PCT/IB2013/052858 priority patent/WO2013153524A1/en
Priority to CA2869696A priority patent/CA2869696A1/en
Priority to US15/855,156 priority patent/US20180284120A1/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57515—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2446/00—Magnetic particle immunoreagent carriers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
GBGB1206323.6A 2012-04-10 2012-04-10 Methods and arrays for use in the same Ceased GB201206323D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1206323.6A GB201206323D0 (en) 2012-04-10 2012-04-10 Methods and arrays for use in the same
CA2869696A CA2869696A1 (en) 2012-04-10 2013-04-10 Methods for determining a breast cancer-associated disease state and arrays for use in the methods
AU2013248138A AU2013248138B2 (en) 2012-04-10 2013-04-10 Methods for determining a breast cancer-associated disease state and arrays for use in the methods
MX2014012192A MX2014012192A (es) 2012-04-10 2013-04-10 Procedimientos para determinar un estado de enfermedad asociado con cancer de mama y matrices para usar en los mismos.
JP2015505056A JP6470681B2 (ja) 2012-04-10 2013-04-10 乳癌関連の疾患状態を決定する方法およびこの方法における使用のためのアレイ
US14/391,144 US20150057177A1 (en) 2012-04-10 2013-04-10 Methods for determining a breast cancer-associated disease state and arrays for use in the methods
CN201710403116.3A CN107782901A (zh) 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列
KR1020147031565A KR20140143457A (ko) 2012-04-10 2013-04-10 유방암-관련 질환 상태를 결정하는 방법 및 그에 사용하기 위한 어레이
EP13775332.3A EP2836838A4 (en) 2012-04-10 2013-04-10 METHOD FOR DETERMINING A DISEASE ASSOCIATED WITH BREAST CANCER AND ARRAYS FOR USE IN THESE METHODS
CN201380029458.3A CN104508486B (zh) 2012-04-10 2013-04-10 用于确定乳癌相关疾病状态的方法和用于该方法中的阵列
PCT/IB2013/052858 WO2013153524A1 (en) 2012-04-10 2013-04-10 Methods for determining a breast cancer-associated disease state and arrays for use in the methods
US15/855,156 US20180284120A1 (en) 2012-04-10 2017-12-27 Methods for determining a breast cancer-associated disease state and arrays for use in the methods

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1206323.6A GB201206323D0 (en) 2012-04-10 2012-04-10 Methods and arrays for use in the same

Publications (1)

Publication Number Publication Date
GB201206323D0 true GB201206323D0 (en) 2012-05-23

Family

ID=46177101

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1206323.6A Ceased GB201206323D0 (en) 2012-04-10 2012-04-10 Methods and arrays for use in the same

Country Status (10)

Country Link
US (2) US20150057177A1 (https=)
EP (1) EP2836838A4 (https=)
JP (1) JP6470681B2 (https=)
KR (1) KR20140143457A (https=)
CN (2) CN107782901A (https=)
AU (1) AU2013248138B2 (https=)
CA (1) CA2869696A1 (https=)
GB (1) GB201206323D0 (https=)
MX (1) MX2014012192A (https=)
WO (1) WO2013153524A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201410226D0 (en) * 2014-06-09 2014-07-23 Immunovia Ab Methods and arrays for use in the same
CN106596494B (zh) * 2016-12-29 2019-05-10 青岛科技大学 一种基于荧光传感阵列的快速筛查早中晚期乳腺癌技术
GB201701572D0 (en) * 2017-01-31 2017-03-15 Immunovia Ab Methods, arrays and uses thereof
CN111458512A (zh) * 2019-01-21 2020-07-28 中国科学院分子细胞科学卓越创新中心 一种动脉粥样硬化生物标志物及其用途
JP7352937B2 (ja) * 2019-07-19 2023-09-29 公立大学法人福島県立医科大学 乳癌のサブタイプを鑑別又は分類するための鑑別マーカー遺伝子セット、方法およびキット
US20240318258A1 (en) * 2021-01-15 2024-09-26 Université De Fribourg Biomarkers for breast cancer detection

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9707125A (pt) * 1996-01-11 1999-07-20 Corixa Corp Composições e processos para o tratamento e diagnóstico de câncer de mama
EP1468110A4 (en) * 2001-06-10 2008-01-30 Irm Llc MOLECULAR SIGNATURES NORMALLY TO THE DEATH LEADING CARCINOME
WO2004106495A2 (en) * 2003-05-29 2004-12-09 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer
EP1639090A4 (en) * 2003-06-09 2008-04-16 Univ Michigan COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
JP2005270093A (ja) * 2004-02-24 2005-10-06 Nippon Medical School 乳癌の術後予後予測に関与する遺伝子
WO2005080570A1 (ja) * 2004-02-24 2005-09-01 Mitsubishi Rayon Co., Ltd. 乳癌の術後予後予測に関与する遺伝子
WO2006105642A1 (en) * 2005-04-05 2006-10-12 British Columbia Cancer Agency Biomarkers for the detection of lung cancer and uses thereof
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
SG142186A1 (en) * 2006-10-20 2008-05-28 Agency Science Tech & Res Breast tumour grading
JP5196465B2 (ja) * 2007-04-24 2013-05-15 公益財団法人東京都農林水産振興財団 Ｍｍｐ遺伝子発現促進剤、および、コラーゲン分解促進剤
NZ562237A (en) * 2007-10-05 2011-02-25 Pacific Edge Biotechnology Ltd Proliferation signature and prognosis for gastrointestinal cancer
GB0723179D0 (en) * 2007-11-27 2008-01-02 Immunovia Ab Diagnostic methods and arrays for use in the same
WO2009132909A1 (en) * 2008-04-29 2009-11-05 Siemens Healthcare Diagnostics Gmbh A method for predicting a clinical response of a patient suffering from or at risk of developing cancer towards a given mode of treatment
JP2010151800A (ja) * 2008-11-06 2010-07-08 Kumamoto Univ 生活習慣病及び／又は癌の診断剤
WO2010076322A1 (en) * 2008-12-30 2010-07-08 Siemens Healthcare Diagnostics Inc. Prediction of response to taxane/anthracycline-containing chemotherapy in breast cancer
WO2010088386A1 (en) * 2009-01-28 2010-08-05 University Of Notre Dame Du Lac Accelerated progression relapse test
CA3043089A1 (en) * 2009-11-23 2011-05-26 Genomic Health, Inc. Methods to predict clinical outcome of cancer
JPWO2011065533A1 (ja) * 2009-11-30 2013-04-18 国立大学法人大阪大学 乳癌術前化学療法に対する感受性の判定方法

Also Published As

Publication number Publication date
CN104508486B (zh) 2019-06-04
AU2013248138A1 (en) 2014-11-27
US20150057177A1 (en) 2015-02-26
WO2013153524A1 (en) 2013-10-17
KR20140143457A (ko) 2014-12-16
EP2836838A1 (en) 2015-02-18
CA2869696A1 (en) 2013-10-17
US20180284120A1 (en) 2018-10-04
AU2013248138B2 (en) 2019-01-17
WO2013153524A9 (en) 2014-03-13
CN104508486A (zh) 2015-04-08
JP2015519043A (ja) 2015-07-09
EP2836838A4 (en) 2016-03-30
MX2014012192A (es) 2015-05-11
CN107782901A (zh) 2018-03-09
JP6470681B2 (ja) 2019-02-13

Similar Documents

Publication Publication Date Title
WO2015067969A3 (en) Method, array and use thereof for determining pancreatic cancer
EP3907509A3 (en) Diagnosis of early stage pancreatic cancer
EA030186B9 (ru) Способ проведения количественных анализов
IN2014CN01970A (https=)
GB201207297D0 (en) Analytical methods and arrays for use in the same
MX363201B (es) Procedimiento, matriz y uso para determinar la presencia de cancer pancreatico.
AR095363A1 (es) Biomarcadores y métodos para el tratamiento de condiciones relacionadas con pd-1 y pd-l1
MX2021006791A (es) Metodos y composiciones para detectar proteinas mal plegadas.
GB2511221A (en) Methods and compositions for classification of samples
MX355416B (es) Biomarcadores de cancer de pulmon y usos de los mismos.
GB201206323D0 (en) Methods and arrays for use in the same
MX2016001719A (es) Metodos y equipos para predecir el riesgo de tener una enfermedad o evento cardiovascular.
EP3557259A3 (en) Methods and arrays for use in the same
GB2509682A (en) Biomarkers useful for detection of tyres, grades and stages of human breast cancer
WO2014162008A3 (en) Biomarker signatures for predicting drug response in hodkin's lymphoma
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
MX2016005313A (es) Deteccion de la actividad de corte de una enzima.
MX359376B (es) Metodo y kit para la determinacion de cobre libre en suero.
BR112017011026A2 (pt) métodos analíticos e arranjos para uso nos mesmos
MX2018015140A (es) Firmas de biomarcadores de lupus eritematoso sistemico y sus usos.
SG10201907690TA (en) Device and method for detecting target molecules
MX384485B (es) Deteccion temprana de preeclampsia.
EA201691168A1 (ru) Способы исследования бета-глюкана
EA201400571A1 (ru) Специфичные к трансресвератролу антитела и их применение
WO2017211893A8 (en) Biomarker signatures of systemic lupus erythematosus and uses thereof

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)